Zotepine versus placebo for schizophrenia

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To review the effects of zotepine compared with placebo for people with schizophrenia or related psychoses. As secondary objectives, we propose to investigate whether people: with schizophrenia described as 'treatment resistant' differed in their response from those whose illness was not designated as such; having predominantly positive or negative symptoms of schizophrenia were more responsive to zotepine than those without this designation; and experiencing their first episode of schizophrenia differed in their response from those at a later stage of their illness. Copyright © 2013 The Cochrane Collaboration.